cFLIP expression correlates with tumour progression and patient outcome in non-Hodgkin lymphomas of low grade of malignancy

British Journal of Haematology

Volumn 132, Issue 5, 2006, Pages 560-570

  Valente, Guido ^a   Manfroi, Federica ^a   Peracchio, Claudia ^a   Nicotra, Giuseppina ^a   Castino, Roberta ^a   Nicosia, Gabriella ^a   Kerim, Simonetta ^b   Isidoro, Ciro ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Apoptosis; Caspases; Chemoresistance; Death factors; Fas; Prognostic factor

Indexed keywords

BLEOMYCIN; CD20 ANTIBODY; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLICE INHIBITORY PROTEIN; FLUDARABINE; FOLINIC ACID; GEMCITABINE; IDARUBICIN; IFOSFAMIDE; METHOTREXATE; MITOXANTRONE; NAVELBINE; PREDNISONE; PSORALEN; RITUXIMAB; VINCRISTINE;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PUVA; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR BIOPSY; TUMOR VOLUME; WORLD HEALTH ORGANIZATION;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOMA, LOW-GRADE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REMISSION INDUCTION; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 33644885746     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05898.x     Document Type: Article

References (31)

1. Abedini M.R. Qiu Q. Yan X. Tsang B.K. 2004 Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro Oncogene 23 6997 7004
2. Benesch M. Platzbecker U. Ward J. Deeg H.J. Leisenring W. 2003 Expression of FLIP (long) and FLIP (short) in bone marrow mononuclear and CD34+ cells in patients with myelodysplastic syndrome: correlation with apoptosis Leukemia 17 2460 2466
3. Bodmer D. Brors D. Pak K. Keithley E.M. Mullen L. Ryan A.F. Gloddek B. 2002 Inflammatory signals increase Fas ligand expression by inner ear cells Journal of Neuroimmunology 129 7 10
4. Cheson B.D. Horning S.J. Coiffier B. Shipp M.A. Fisher R.I. Connors J.M. Lister T.A. Vose J. Grillo-Lopez A. Hagenbeek A. Cabanillas F. Klippensten D. Hiddemann W. Castellino R. Harris N.L. Armitage J.O. Carter W. Hoppe R. Canellos G.P. 1999 Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group Journal of Clinical Oncology 17 1244
5. Djerbi M. Screpanti V. Catrina A.I. Bogen B. Biberfeld P. Grandien A. 1999 The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors Journal of Experimental Medicine 19 1025 1032
6. Dutton A. O'Neil J.D. Milner A.E. Reynolds G.M. Starczynski J. Crocker J. Young L.S. Murray P. 2004 Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death Proceedings of the National Academy of Sciences of the United States of America 101 6611 6616
7. Harris N.L. Jaffe E.S. Diebold J. Flandrin G. Muller-Hermelink H.K. Vardiman J. Lister T.A. Bloomfield C.D. 1999 The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues Annals of Oncology 10 1419 1432
8. Hennino A. Berard M. Krammer P.H. Defrance T. 2001 FLICE-inhibitory protein is a key regulator of germinal center B cell apoptosis Journal of Experimental Medicine 193 447 458
9. Irisarri M. Plumas J. Bonnefoix T. Jacob M.C. Roucard C. Pasquier M.A. Sotto J.J. Lajmanovich A. 2000 Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line Leukemia 14 2149 2158
10. Jaffe E.S. Harris N.L. Stein H. Vardiman J.W. 2001 World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissue IARC Lyon, France
11. Jeon Y.K. Kim H. Park S.O. Choi H.Y. Kim Y.A. Park S.S. Kim J.E. Kim Y.N. Kim C.W. 2005 Resistance to Fas-mediated apoptosis is restored by cycloheximide through the downregulation of cellular FLIP(L) in NK/T-cell lymphoma Laboratory Investigation 85 874 884
12. Jones D.T. Ganeshaguru K. Virchis A.E. Folarin N.I. Lowdell M.W. Mehta A.B. Prentice H.G. Hoffbrand A.V. Wickremasinghe R.G. 2001 Caspase 8 activation independent of Fas (CD95/Apo1) signalling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation Blood 98 2800 2807
13. Kerr J.F. Wyllie A.H. Currie A.R. 1972 Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics British Journal of Cancer 26 239 257
14. Kim Y.Y. Park B.J. Seo G.J. Lim J.Y. Lee S.M. Kimm K.C. Park C. Kim J. Park S.I. 2003 Long form of cellular FLICE-inhibitory protein interacts with Daxx and prevents Fas-induced JNK activation Biochemical and Biophysical Research Communications 312 426 433
15. Kischkel F.C. Hellbardt S. Behrmann I. Germer M. Pawlita M. Krammer P.H. Peter M.E. 1995 Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor EMBO Journal 4 5579 5588
16. Krueger A. Schmitz I. Baumann S. Krammer P.H. Kirchhoff S. 2001 Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex Journal of Biological Chemistry 276 20633 20640
17. Lajmanovich A. Irisarri M. Molens J.P. Pasquier M.A. Sotto J.J. Bensa J.C. Leroux D. Plumas J. 2004 Impairment of death-inducing signalling complex formation in CD95-resistant human primary lymphoma B cells British Journal of Haematology 124 746 753
18. Mathas S. Lietz A. Anagnostopoulos I. Hummel F. Wiesner B. Janz M. Jundt F. Hirsch B. Johrens-Leder K. Vornlocher H.P. Bommert K. Stein H. Dorken B. 2004 c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis Journal of Experimental Medicine 199 1041 1052
19. Medema J.P. de Jong J. van Hall T. Melief C.J. Offringa R. 1999 Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein Journal of Experimental Medicine 190 1033 1038
20. Micheau O. Thome M. Schneider P. Holler N. Tschopp J. Nicholson D.W. Briand C. Grutter M.G. 2002 The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex Journal of Biological Chemistry 277 45162 45171
21. Pedersen J.M. Kitada S. Schimmer A. Kim Y. Zapata J.M. Charboneau L. Rassenti L. Andreeff M. Bennett F. Sporn M.B. Liotta L.D. Kipps T.J. Reed J.C. 2002 The triterpenoid CDDO induces apoptosis in refractory CLL B cells Blood 100 2965 2972
22. Rossi D. Gaidano G. 2003 Messengers of cell death: apoptotic signaling in health and disease Haematologica 88 212 218
23. Sanchez-Beato M. Sanchez-Aguilera A. Piris M.A. 2003 Cell cycle deregulation in B-cell lymphomas Blood 101 1220 1235
24. Scaffidi C. Schmitz I. Krammer P.H. Peter M.E. 1999 The role of c-FLIP in modulation of CD95-induced apoptosis Journal of Biological Chemistry 274 1541 1548
25. Song J.H. Song D.K. Herlyn M. Petruk K.C. Hao C. 2003 Cisplatin down-regulation of cellular Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory proteins to restore tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human melanoma cells Clinical Cancer Research 9 4255 4266
26. Thomas R.K. Kallenborn A. Wickenhauser C. Schultze J.L. Draube A. Vockerodt M. Re D. Diehl V. Wolf J. 2002 Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells American Journal of Pathology 160 1521 1528
27. Thome M. Tschopp J. 2001 Regulation of lymphocyte proliferation and death by FLIP. Nature Reviews Immunology 1 50 58
28. Uherova P. Olson S. Thompson M.A. Juskevicius R. Hamilton K.S. 2004 Expression of c-FLIP in classic and nodular lymphocyte-predominant Hodgkin lymphoma Applied Immunohistochemistry and Molecular Morphology 12 105 110
29. Valnet-Rabier M.B. Challier B. Thiebault S. Angonin R. Margueritte G. Mougin C. Kantelip B. Decooninck E. Cahn J.Y. Fest T. 2005 c-Flip protein expression in Burkitt's lymphomas is associated with a poor clinical outcome British Journal of Haematology 128 767 773
30. Van Eijk M. Medema J.P. de Groot C. 2001 Cutting edge: cellular Fas-associated death domain-like IL-1-converting enzyme-inhibitory protein protects germinal center B cells from apoptosis during germinal center reactions Journal of Immunology 166 6473 6476
31. Zhang L. Fang B. 2005 Mechanisms of resistance to TRAIL-induced apoptosis in cancer Cancer Gene Therapy 12 228 237